News

ImpediMed Limited, a global provider of medical technology to non-invasively measure, monitor and manage tissue composition and fluid status using bioimpedance spectroscopy (BIS), announces that the first patient has been enrolled in its...

Cardialen, Inc., a medical device company developing a low-energy implantable defibrillation therapy designed to more gently restore normal heart rhythm, announced the closing of a $17 million Series B investment led by RiverVest Venture...

Geneva Health Solutions (GHS), the leading cloud-based technology platform and service for managing data from implantable cardiac devices, has formalized its internal training systems by launching Geneva University, a business unit within...

Bardy Diagnostics, Inc., a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced it was awarded an Innovative Technology contract with Vizient, Inc. for the Carnation Ambulatory Monitor ("CAM™"),...

Imricor announced that it signed its first commercialization contract for the Advantage-MR EP Recorder/Stimulator System and supporting Vision-MR devices1 with the Heart Center Dresden in Germany. This agreement places the Heart Center...

Adagio Medical, Inc., the developer of the iCLAS™ technology, the company's ultra-low temperature intelligent continuous lesion ablation system for the treatment of cardiac arrhythmias, announces that the first patients were successfully...

Johnson & Johnson Medical Devices Companies* announced that Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of heart arrhythmias, has received approval from the U.S. Food and Drug Administration (FDA)...

In celebration of National Atrial Fibrillation (Afib) Awareness Month, patient advocacy organization StopAfib.org announced the results of a national online survey conducted by The Harris Poll of more than 400 people (aged 45 and older)...

Verseon, a technology-based pharmaceutical company, announced that it has received ethics committee approval and acknowledgement from the Therapeutic Goods Administration in Australia for the phase I clinical trial of VE-1902, the first...

Baylis Medical Company, a leader in the development, manufacturing and commercialization of cardiology devices, announced the official commercial launch of its SureFlex® Steerable Guiding Sheath. The SureFlex sheath is part of Baylis'...